SecBot SecBot
PRESS-RELEASE ·Filed May 5, 2026

XRAY

DENTSPLY SIRONA Inc.
MIXED
Impact 5/10
Horizonimmediate Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

Revenue beat and maintained guidance provide near-term support, but organic sales decline and margin compression signal underlying weakness. Watch for commentary on demand trends and restructuring execution on the earnings call for direction.

DirectionMixed
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$11.14
T+0 close · May 5, 2026 · via day close
Latest settled
+20.02%
T+60 · $13.37
Vs SPY
+17.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $11.14entry
  2. T+1 · 6mo ago 0.00%α +0.33% · $11.14
  3. T+5 · 6mo ago −1.26%α −2.39% · $11.00
  4. T+20 · 6mo ago −13.46%α −16.25% · $9.64
  5. T+60 · 4mo ago +20.02%α +17.96% · $13.37
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dentsply Sirona reported Q1 2026 revenue of $880M, beating consensus of $840.1M by 4.7%, while adjusted EPS of $0.27 matched consensus. However, constant currency sales declined 6.7% YoY, adjusted EPS fell 39% YoY, and GAAP net loss was ($0.05)/share. The company reiterated its 2026 outlook, signaling confidence despite near-term headwinds. The mixed results reflect execution of its Return-to-Growth plan amid external pressures.

Key Financial Metrics

EPS
$0.27
est $0.27 · 0.0%
Revenue
$880.0M
est $840.1M · +4.8% · +0.1% YoY
Rating
in line
Guidance
$3.5 billion to $3.6 billion
maintained
Free Cash Flow
-$12.0M
Gross Margin
48.5%

Key Facts

  • Revenue $880M vs consensus $840.1M (beat by 4.7%)
  • Adjusted EPS $0.27 in line with consensus, down 39% YoY from $0.44
  • GAAP net loss per share ($0.05) vs income $0.10 in prior year
  • Constant currency sales declined 6.7% YoY
  • Adjusted EBITDA margin fell to 14.7% from 19.0%
  • Maintained 2026 guidance: net sales $3.5B-$3.6B, adjusted EPS $1.40-$1.50
  • Operating cash flow improved to $40M vs $7M, free cash flow negative ($12M)

Financial Impact

Revenue beat of $39.9M but adjusted EPS down 39% YoY with organic sales decline of 6.7%

revenueepsmarginscash flow

Risk Factors

  • Continued organic revenue decline and market share loss
  • Restructuring execution risks and cost headwinds
  • Debt level of $2.2B with elevated interest expense

Market Snapshot

Exchange
Nasdaq
Sector
Dental Equipment & Supplies
Analyst Consensus
36% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3288198

US Market Status

Market Closed · Opens in 6h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026